N2- ((1S)- 1- carboxy- 3- phenylpropyl)- N6- ((4- hydroxyphenyl)iminomethyl)- L- lysyl- L-proline

p-hydroxybenzamidine deriv of MK 521; structure given in first source

Also Known As:

L-proline, N2-((1S)-1-carboxy-3-phenylpropyl)-N6-((4-hydroxyphenyl)iminomethyl)-L-lysyl-; MK 351A; MK-351A; MK-521-4-hydroxybenzamidine; MK351A; compound 351 A; compound 351-A; L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-N6-((4-hydroxyphenyl)iminomethyl)-L-lysyl)-, (S)-

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - Dipeptides: 945
      - N2-((1S)-1-carboxy-3-phenylpropyl)-N6-((4-hydroxyphenyl)iminomethyl)-L-lysyl- L-proline: 1

Related Diseases

1.	Hyperoxia 01/01/1988 - "Lung MK 351A uptake after hypoxia adaptation and subsequent hyperoxia exposure."
2.	Hypoxia (Hypoxemia) 01/01/1988 - "Lung MK 351A uptake after hypoxia adaptation and subsequent hyperoxia exposure."